Literature DB >> 16562827

Antineoplastic agents. 551. Isolation and structures of bauhiniastatins 1-4 from Bauhinia purpurea.

George R Pettit1, Atsushi Numata, Chika Iwamoto, Yoshihide Usami, Takeshi Yamada, Hirofumi Ohishi, Gordon M Cragg.   

Abstract

Bioassay-guided (P388 lymphocytic leukemia cell line) separation of extracts prepared from the leaves, stems, and pods of Bauhinia purpurea, and, in parallel, its roots, led to the isolation of four new dibenz[b,f]oxepins (2a, 3-5) named bauhiniastatins 1-4, as well as the known and related pacharin (1) as cancer cell growth inhibitors. The occurrence of oxepin derivatives in nature is quite rare. Bauhiniastatins 1-4 were found to exhibit significant growth inhibition against a minipanel of human cancer cell lines, and bauhiniastatin 1 (2a) was also found to inhibit the P388 cancer cell line. Structures for these new cancer cell growth inhibitors were established by spectroscopic techniques that included HRMS and 2D NMR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16562827     DOI: 10.1021/np058075+

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  10 in total

1.  Evaluation of Antimicrobial Activity of Bauhinia purpurea Leaves Under In Vitro Conditions.

Authors:  Bhawna Sunil Negi; Bharti P Dave; Y K Agarwal
Journal:  Indian J Microbiol       Date:  2012-03-25       Impact factor: 2.461

2.  New oxacycles on the block: benzodioxepinones via a Passerini reaction.

Authors:  Michael Fragkiadakis; Marios Zingiridis; Edward Loukopoulos; Constantinos G Neochoritis
Journal:  Mol Divers       Date:  2022-07-28       Impact factor: 3.364

3.  Chromatography Conditions Development by Design of Experiments for the Chemotype Differentiation of Four Bauhinia Species.

Authors:  Amanda J Aquino; Edenir R Pereira-Filho; Regina V Oliveira; Quezia B Cass
Journal:  Front Chem       Date:  2022-05-23       Impact factor: 5.545

4.  Evaluation of Wound Healing Potential of Bauhinia purpurea Leaf Extracts in Rats.

Authors:  K V Ananth; M Asad; N Prem Kumar; S M B Asdaq; G S Rao
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

5.  Screening of Bauhinia purpurea Linn. for analgesic and anti-inflammatory activities.

Authors:  C S Shreedhara; V P Vaidya; H M Vagdevi; K P Latha; K S Muralikrishna; A M Krupanidhi
Journal:  Indian J Pharmacol       Date:  2009-04       Impact factor: 1.200

6.  Larvicidal activity against Aedes aegypti of pacharin from Bauhinia acuruana.

Authors:  Roberto Wagner da Silva Góis; Leôncio Mesquita de Sousa; Gilvandete Maria Pinheiro Santiago; Nirla Rodrigues Romero; Telma Leda Gomes Lemos; Angela Martha Campos Arriaga; Raimundo Braz-Filho
Journal:  Parasitol Res       Date:  2013-04-20       Impact factor: 2.289

7.  Palladium-Catalyzed Cascade to Benzoxepins by Using Vinyl-Substituted Donor-Acceptor Cyclopropanes.

Authors:  Matteo Faltracco; Koen N A van de Vrande; Martijn Dijkstra; Jordy M Saya; Trevor A Hamlin; Eelco Ruijter
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-26       Impact factor: 15.336

8.  New short strategy for the synthesis of the dibenz[b,f]oxepin scaffold.

Authors:  David R R Moreno; Giorgio Giorgi; Cristian O Salas; Ricardo A Tapia
Journal:  Molecules       Date:  2013-11-29       Impact factor: 4.411

9.  Synthesis and Investigations of Building Blocks with Dibenzo[b,f] Oxepine for Use in Photopharmacology.

Authors:  Piotr Tobiasz; Filip Borys; Marta Borecka; Hanna Krawczyk
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

10.  In-vitro activity of saponins of bauhinia purpurea, madhuca longifolia, celastrus paniculatus and semecarpus anacardium on selected oral pathogens.

Authors:  K S Jyothi; M Seshagiri
Journal:  J Dent (Tehran)       Date:  2012-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.